These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 33231563)
21. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis. Gong J; Ma L; Peng C; Liu J Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487 [TBL] [Abstract][Full Text] [Related]
22. Novel insights for lncRNA MAGI2-AS3 in solid tumors. Xue C; Li G; Lu J; Luo J; Jia J Biomed Pharmacother; 2021 May; 137():111429. PubMed ID: 33761624 [TBL] [Abstract][Full Text] [Related]
23. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis. Ren H; Li Z; Tang Z; Li J; Lang X J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544 [TBL] [Abstract][Full Text] [Related]
24. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells. Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745 [TBL] [Abstract][Full Text] [Related]
25. Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling. Chen JB; Zhu YW; Guo X; Yu C; Liu PH; Li C; Hu J; Li HH; Liu LF; Chen MF; Chen HQ; Xiong-Bing Z J Cell Physiol; 2019 Aug; 234(8):13592-13601. PubMed ID: 30609030 [TBL] [Abstract][Full Text] [Related]
26. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6. Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700 [TBL] [Abstract][Full Text] [Related]
27. LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells. Cui S; Liu Z; Tang B; Wang Z; Li B BMC Musculoskelet Disord; 2020 Mar; 21(1):149. PubMed ID: 32143617 [TBL] [Abstract][Full Text] [Related]
28. Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis. He J; Zhou X; Li L; Han Z Cancer Manag Res; 2020; 12():289-302. PubMed ID: 32021443 [TBL] [Abstract][Full Text] [Related]
29. MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2. Xu X; Yuan X; Ni J; Guo J; Gao Y; Yin W; Li F; Wei L; Zhang J J Cell Physiol; 2021 Feb; 236(2):1116-1130. PubMed ID: 32730644 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3. Xu Z; Chen Z; Peng M; Zhang Z; Luo W; Shi R; Wang L; Hong Y Bioengineered; 2022 Feb; 13(2):2673-2685. PubMed ID: 35043728 [TBL] [Abstract][Full Text] [Related]
31. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p. Dong Z; Hu B; Wang S; Wang M; Sun S; Liu X; Li D; Wu D J Orthop Surg Res; 2024 Jun; 19(1):370. PubMed ID: 38907263 [TBL] [Abstract][Full Text] [Related]
32. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis. Hao XZ; Yang K Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127 [TBL] [Abstract][Full Text] [Related]
33. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma. Wang G; Li H; Hou Y Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044 [TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA MAGI2 Wei X; Hou Y; Zhang Y; Zhang H; Sun Z; Meng X; Wang Z J Cancer; 2022; 13(1):343-353. PubMed ID: 34976194 [TBL] [Abstract][Full Text] [Related]
35. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression. Mao W; Huang X; Wang L; Zhang Z; Liu M; Li Y; Luo M; Yao X; Fan J; Geng J J Exp Clin Cancer Res; 2019 Apr; 38(1):169. PubMed ID: 30999937 [TBL] [Abstract][Full Text] [Related]
36. LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis. Hou A; Zhang Y; Fan Y; Zheng Y; Zhou X; Liu H Cancer Manag Res; 2020; 12():4209-4216. PubMed ID: 32581592 [TBL] [Abstract][Full Text] [Related]
37. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway. Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978 [TBL] [Abstract][Full Text] [Related]
38. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia. Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258 [TBL] [Abstract][Full Text] [Related]
39. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a. Li D; Wang J; Zhang M; Hu X; She J; Qiu X; Zhang X; Xu L; Liu Y; Qin S Mol Ther Nucleic Acids; 2020 Mar; 19():109-123. PubMed ID: 31837602 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer. Zhang X; Jiang Y; Xie Y; Leng X; Song F DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]